Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) or Lou Gehrig's disease, is a rare and devastating neurodegenerative disease that affects the motor neurons responsible for controlling voluntary muscles. This progressive disease results in the gradual loss of muscle control, leading to difficulties with movement, speech, swallowing, and eventually breathing. Unfortunately, there are currently few therapeutics available that can halt, delay, or reverse the progression of ALS. As such, there is an urgent need for the development of effective treatments for ALS to improve the quality of life for individuals affected by this devastating disease.